Vital Signs - Pulmonary Drug Delivery: Going Beyond Lung Diseases
Vital Signs - Pulmonary Drug Delivery: Going Beyond Lung Diseases
RELEASE DATE
21-Jun-2010
21-Jun-2010
REGION
North America
North America
Research Code: 9561-00-A9-00-00
SKU: HC00598-NA-MR_04071
$1,500.00
Special Price $1,125.00 save 25 %
In stock
SKU
HC00598-NA-MR_04071
Description
This issue of Vital Signs, released on June 21, 2010, provides a strategic analysis of trends in pulmonary drug delivery outside of respiratory diseases. Additionally, a company spotlight is provided for ZIOPHARM Oncology, a company focused on the research and development of small molecule therapies for the treatment of cancer. Reimbursement and regulatory news from the FDA is also provided for the week of May 31, 2010.
Table of Contents
This week's issue:
Related Research
Popular Topics
This issue of Vital Signs, released on June 21, 2010, provides a strategic analysis of trends in pulmonary drug delivery outside of respiratory diseases. Additionally, a company spotlight is provided for ZIOPHARM Oncology, a company focused on the research and development of small molecule therapies for the treatment of cancer. Reimbursement and regulatory news from the FDA is also provided for the week of May 31, 2010.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | 9561-00-A9-00-00 |
Is Prebook | No |